Close Menu

Prometheus Laboratories

PredictImmune's test relies on a 16-marker panel run using quantitative PCR to stratify Crohn's disease and ulcerative colitis patients according to the severity of their illnesses.

The Medicare contractor proposed coverage for several cancer assays, but would not cover molecular respiratory virus assays or a test for inflammatory bowel disease.

VANCOUVER, BC – At the American Society for Mass Spectrometry annual meeting here this week a number of major vendors reiterated their commitment to moving their instruments into the clinic (

Shares of Rosetta Genomics got a major boost this week after the company effected a one-for-fifteen reverse stock split, and then announced it had launched a new microRNA-based diagnostic and had obtained Medicare coverage for its flagship cancer of unknown primary origin microRN

The University of California of Oakland has received US Patent No. 8,162,555, "Printing pins having selective wettability and method of making same." Printing pins are described that have an exterior surface and an interior surface that defines a lumen or capillary tract.

NEW YORK (GenomeWeb News) – The US Supreme Court today invalidated two patents held by Prometheus Laboratories in a widely watched case for those involved in the personalized medicine field.

Rosetta Genomics last week said that it has avoided bankruptcy by coming up with money owed to one-time partner Prometheus Laboratories.
Rosetta said that it has paid Prometheus $650,000, plus accrued and unpaid interest, on a promissory note that was due Nov. 22.

NEW YORK (GenomeWeb News) – Rosetta Genomics disclosed after the close of the market on Thursday that it has paid $650,000 it owed to Prometheus Laboratories.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.